249 results
Page 3 of 13
8-K
EX-4.1
b6al94s3k4me h2w
4 Feb 21
Entry into a Material Definitive Agreement
12:00am
8-K/A
EX-99.3
x4d05z vo
30 Dec 20
Financial Statements and Exhibits
5:13pm
D
vlm6nq npwsvl9soer
20 Nov 20
$21.15M in equity / options / securities to be acquired, sold $21.15M, 18 investors
3:21pm
8-K
EX-3.3
5ljk1cx1
6 Nov 20
Ocuphire Pharma Completes Transactions and Begins Trading on Nasdaq as OCUP
9:18am
8-K
EX-10.4
zv3bkzo
6 Nov 20
Ocuphire Pharma Completes Transactions and Begins Trading on Nasdaq as OCUP
9:18am
8-K
EX-14.1
qb4xkj30i5hgp
6 Nov 20
Ocuphire Pharma Completes Transactions and Begins Trading on Nasdaq as OCUP
9:18am
8-K
EX-10.8
0g1x9qs
6 Nov 20
Ocuphire Pharma Completes Transactions and Begins Trading on Nasdaq as OCUP
9:18am
8-K
u9abs8ynaos0bhcr
9 Oct 20
Other Events
4:03pm
425
qj8lx8q efv7
9 Oct 20
Business combination disclosure
4:01pm
424B3
lypj74yha8 e3g6wnmv7
2 Oct 20
Prospectus supplement
9:25am
S-4/A
EX-10.45
en8ixt1x62x4wf4
27 Aug 20
Registration of securities issued in business combination transactions (amended)
5:04pm
S-4/A
b8mooy w37
27 Aug 20
Registration of securities issued in business combination transactions (amended)
5:04pm
S-4
EX-10.41
11zx3
6 Jul 20
Registration of securities issued in business combination transactions
4:08pm
S-4
EX-10.26
dqjo53
6 Jul 20
Registration of securities issued in business combination transactions
4:08pm